FXAIX
Price
$234.61
Change
+$1.36 (+0.58%)
Updated
Oct 8 closing price
Net Assets
722.95B
PRSRX
Price
$59.65
Change
+$0.39 (+0.66%)
Updated
Oct 8 closing price
Net Assets
655.02M
Interact to see
Advertisement

FXAIX vs PRSRX

Header iconFXAIX vs PRSRX Comparison
Open Charts FXAIX vs PRSRXBanner chart's image
Fidelity 500 Index
Price$234.61
Change+$1.36 (+0.58%)
VolumeN/A
Net Assets722.95B
Putnam U.S. Research R
Price$59.65
Change+$0.39 (+0.66%)
VolumeN/A
Net Assets655.02M
FXAIX vs PRSRX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. PRSRX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and PRSRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 723B vs. PRSRX (655M). FXAIX pays higher dividends than PRSRX: FXAIX (1.12) vs PRSRX (0.21). FXAIX was incepted earlier than PRSRX: FXAIX (14 years) vs PRSRX (23 years). PRSRX (1.26) is less costly to investors than FXAIX (0.01). PRSRX is a more actively managed with annual turnover of: 35.00 vs. FXAIX (2.00). FXAIX (0) and PRSRX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 18.25 vs. PRSRX (9.62). FXAIX return over 5 years is better than : 107.85 vs. PRSRX (62.60).
FXAIXPRSRXFXAIX / PRSRX
Total Expense Ratio0.011.141%
Annual Report Gross Expense Ratio0.011.261%
Fund Existence14 years23 years-
Gain YTD15.27115.42299%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets723B655M110,382%
Annual Yield % from dividends1.120.21542%
Returns for 1 year18.259.62190%
Returns for 3 years92.7470.03132%
Returns for 5 years107.8562.60172%
Returns for 10 years267.08149.75178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERO2.690.32
+13.50%
Venus Concept
ATKR64.561.95
+3.11%
Atkore
USNA26.510.18
+0.68%
USANA Health Sciences
EQ1.47-0.02
-1.34%
Equillium
EVR318.00-6.15
-1.90%
Evercore